Pellegrini-Bouiller et al. analyzed PIT1 and D2R gene expression in a series of 30 human lactotroph and somatotroph pituitary tumors, identifying a positive correlation between PIT1 mRNA and D2R mRNA levels, which in turn is associated with therapeutic responsiveness to DAs [66]. This evidence concerns the gene DRD2 and pituitary tumor.